Video Latest - ecancer

Can we reduce the intensity of frontline therapy?

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

18 Oct 2018

For HSCT in Ph-positive ALL

Prof Oliver Ottmann - Cardiff University, Cardiff, UK

18 Oct 2018

Against HSCT in Ph-positive ALL

Prof Robin Foa - Professor of Haematology and Head of Haematology, University of Rome, Rome, Italy

18 Oct 2018

Management of MLL-rearranged ALL

Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht, Netherlands

18 Oct 2018

Transplanting adult ALL patients

Prof Sebastien Giebel - The Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland

18 Oct 2018

Editor's Choice for August 2018

Prof Gordon McVie - Founding Editor, ecancer

22 Aug 2018

Treating myelodysplastic syndromes

Prof Hugo Fernandez - Moffitt Cancer Center, Tampa, USA

7 Aug 2018

Updates on data and results from PROPHECY, PALOMA-3 and CHECKMATE-227

Ignacio Gil-Bazo - Clínica Universidad de Navarra, Pamplona, Spain

7 Aug 2018

Two important pancreatic studies: PRODIGE 24 and PREOPANC

Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA

7 Aug 2018

Several important studies for lung cancer

Prof Luis Raez - Herbert Wertheim College of Medicine, Miami, USA

7 Aug 2018

The ICMC: a new path for microbiome research

Prof Julian Marchesi - Imperial College London, London, UK

19 Jul 2018

The microbiome and cancer: cause or correlation?

Dr James Kinross - Imperial College London, London, UK

19 Jul 2018

Video